Germline and sporadic cancers driven by the RAS pathway: parallels and contrasts
Affiliation
Manchester University NHS Foundation Trust, Manchester, United Kingdom.Issue Date
2020
Metadata
Show full item recordCitation
Ettl J, Tolaney S, Wardley A, Zambelli S, Hilton JF, Ricci F, et al. Monarcher: A Randomized Phase 2 Study of Abemaciclib Plus Trastuzumab with or without Fulvestrant Versus Trastuzumab Plus Standard-of-Care Chemotherapy in Women with HR+, HER2+Advanced Breast Cancer. Oncology Research and Treatment. 2020;43:16-Journal
Annals of OncologyDOI
10.1016/j.annonc.2020.03.291PubMed ID
32240795Additional Links
https://dx.doi.org/10.1016/j.annonc.2020.03.291Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/j.annonc.2020.03.291
Scopus Count
Collections
Related articles
- Advancing RAS/RASopathy therapies: An NCI-sponsored intramural and extramural collaboration for the study of RASopathies.
- Authors: Gross AM, Frone M, Gripp KW, Gelb BD, Schoyer L, Schill L, Stronach B, Biesecker LG, Esposito D, Hernandez ER, Legius E, Loh ML, Martin S, Morrison DK, Rauen KA, Wolters PL, Zand D, McCormick F, Savage SA, Stewart DR, Widemann BC, Yohe ME
- Issue date: 2020 Apr
- A review of craniofacial and dental findings of the RASopathies.
- Authors: Cao H, Alrejaye N, Klein OD, Goodwin AF, Oberoi S
- Issue date: 2017 Jun
- [New insight of craniofacial and oral findings of the RASopathies].
- Authors: Cao HT, Yang YJ, Zheng Q, Shi B, Li CH
- Issue date: 2018 Dec 9
- The RASopathies: from pathogenetics to therapeutics.
- Authors: Hebron KE, Hernandez ER, Yohe ME
- Issue date: 2022 Feb 1
- NRAS associated RASopathy and embryonal rhabdomyosarcoma.
- Authors: Garren B, Stephan M, Hogue JS
- Issue date: 2020 Jan